Cargando…
Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature
BACKGROUND: Ameloblastoma is a rare benign odontogenic tumor with locally aggressive behavior and a high recurrence rate. When metastases occur, which are uncommon, lungs constitute the most frequent site involved. Malignant ameloblastomas are different from ameloblastic carcinomas. Malignant amelob...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198715/ https://www.ncbi.nlm.nih.gov/pubmed/21968082 http://dx.doi.org/10.1186/1752-1947-5-491 |
_version_ | 1782214478561017856 |
---|---|
author | Amzerin, Mounia Fadoukhair, Zouhour Belbaraka, Rhizlane Iraqui, Meryem Boutayeb, Saber M'rabti, Hind Kebdani, Tayeb Hassouni, Khaled Benjaafar, Najib El Gueddari, Brahim K Errihani, Hassan |
author_facet | Amzerin, Mounia Fadoukhair, Zouhour Belbaraka, Rhizlane Iraqui, Meryem Boutayeb, Saber M'rabti, Hind Kebdani, Tayeb Hassouni, Khaled Benjaafar, Najib El Gueddari, Brahim K Errihani, Hassan |
author_sort | Amzerin, Mounia |
collection | PubMed |
description | BACKGROUND: Ameloblastoma is a rare benign odontogenic tumor with locally aggressive behavior and a high recurrence rate. When metastases occur, which are uncommon, lungs constitute the most frequent site involved. Malignant ameloblastomas are different from ameloblastic carcinomas. Malignant ameloblastomas are tumors considered metastatic despite the appearance of well-differentiated or benign histology, while ameloblastic carcinomas are histologically malignant in both primary and metastatic sites. CASE PRESENTATION: A 24-year-old Moroccan man presented a malignant ameloblastoma of the mandible. The tumor was entirely resected. Five years later, a local recurrence occurred. Our patient was treated by exclusive radiotherapy with persistence of a residual disease. After two years he developed multiple lung metastases. Our patient received a combination chemotherapy using doxorubicin and cisplatin. CONCLUSION: Less than 50 cases of ameloblastoma with metastases have been reported. There is still no standard treatment for metastatic ameloblastoma. Only through continuous reporting of such cases will clinicians be able to draw an optimal strategy for management of this pathology. |
format | Online Article Text |
id | pubmed-3198715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31987152011-10-23 Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature Amzerin, Mounia Fadoukhair, Zouhour Belbaraka, Rhizlane Iraqui, Meryem Boutayeb, Saber M'rabti, Hind Kebdani, Tayeb Hassouni, Khaled Benjaafar, Najib El Gueddari, Brahim K Errihani, Hassan J Med Case Reports Case Report BACKGROUND: Ameloblastoma is a rare benign odontogenic tumor with locally aggressive behavior and a high recurrence rate. When metastases occur, which are uncommon, lungs constitute the most frequent site involved. Malignant ameloblastomas are different from ameloblastic carcinomas. Malignant ameloblastomas are tumors considered metastatic despite the appearance of well-differentiated or benign histology, while ameloblastic carcinomas are histologically malignant in both primary and metastatic sites. CASE PRESENTATION: A 24-year-old Moroccan man presented a malignant ameloblastoma of the mandible. The tumor was entirely resected. Five years later, a local recurrence occurred. Our patient was treated by exclusive radiotherapy with persistence of a residual disease. After two years he developed multiple lung metastases. Our patient received a combination chemotherapy using doxorubicin and cisplatin. CONCLUSION: Less than 50 cases of ameloblastoma with metastases have been reported. There is still no standard treatment for metastatic ameloblastoma. Only through continuous reporting of such cases will clinicians be able to draw an optimal strategy for management of this pathology. BioMed Central 2011-10-03 /pmc/articles/PMC3198715/ /pubmed/21968082 http://dx.doi.org/10.1186/1752-1947-5-491 Text en Copyright ©2011 Amzerin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Amzerin, Mounia Fadoukhair, Zouhour Belbaraka, Rhizlane Iraqui, Meryem Boutayeb, Saber M'rabti, Hind Kebdani, Tayeb Hassouni, Khaled Benjaafar, Najib El Gueddari, Brahim K Errihani, Hassan Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature |
title | Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature |
title_full | Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature |
title_fullStr | Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature |
title_full_unstemmed | Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature |
title_short | Metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature |
title_sort | metastatic ameloblastoma responding to combination chemotherapy: case report and review of the literature |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198715/ https://www.ncbi.nlm.nih.gov/pubmed/21968082 http://dx.doi.org/10.1186/1752-1947-5-491 |
work_keys_str_mv | AT amzerinmounia metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT fadoukhairzouhour metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT belbarakarhizlane metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT iraquimeryem metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT boutayebsaber metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT mrabtihind metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT kebdanitayeb metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT hassounikhaled metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT benjaafarnajib metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT elgueddaribrahimk metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature AT errihanihassan metastaticameloblastomarespondingtocombinationchemotherapycasereportandreviewoftheliterature |